KRISTEN OSTERRIEDER: Open Payments
NPI 1235460064 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 33 payments from 11 companies in 2025. Trend: 2023 $1,461 · 2024 $470 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $261 |
| Amgen Inc. | 9 | $236 |
| Abbott Laboratories | 2 | $199 |
| Medtronic, Inc. | 2 | $68 |
| Corcept Therapeutics | 2 | $39 |
| Sequel Med Tech, LLC | 2 | $30 |
| Hologic Sales and Service, LLC | 1 | $27 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
Products named: FREESTYLE LIBRE 3, Rybelsus, Ozempic, MINIMED 780G, Korlym, TEPEZZA, REPATHA, TWIIST.
Industry payments across GA — which companies pay providers there.
